Quantum-Si Incorporated is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey Alan Hawkins, with a market cap of $165.3M.
Upcoming earnings announcement for Quantum-Si Incorporated
Past 12 earnings reports for Quantum-Si Incorporated
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.08Est: -$0.13 | +38.5% | $451.0KEst: $809.2K | -44.3% | — |
| Nov 5, 2025 | Q3 2025 | -$0.17Est: -$0.14 | -21.4% | $552.0KEst: $587.6K | -6.1% | |
| Aug 5, 2025 | Q2 2025 | -$0.16Est: -$0.14 | -14.3% | $591.0KEst: $1.3M | -53.6% | |
| May 15, 2025 | Q1 2025 | -$0.11Est: -$0.14 | +21.4% | $842.0KEst: $962.3K | -12.5% | |
| Mar 3, 2025 | Q4 2024 | -$0.23Est: -$0.19 | -21.1% | $1.2MEst: $1.2M | -3.1% | |
| Nov 12, 2024 | Q3 2024 | -$0.18Est: -$0.19 | +5.3% | $787.0KEst: $1.1M | -27.1% | |
| Aug 7, 2024 | Q2 2024 | -$0.16Est: -$0.19 | +15.8% | $622.0KEst: $680.0K | -8.5% | |
| May 9, 2024 | Q1 2024 | -$0.14Est: -$0.20 | +30.0% | $457.0KEst: $430.0K | +6.3% | |
| Feb 29, 2024 | Q4 2023 | -$0.16Est: -$0.18 | +11.1% | $400.0KEst: $300.0K | +33.3% | |
| Nov 9, 2023 | Q3 2023 | -$0.17Est: -$0.19 | +10.5% | $223.0KEst: $400.0K | -44.3% | — |
| Aug 7, 2023 | Q2 2023 | -$0.18Est: -$0.20 | +10.0% | $205.0KEst: $400.0K | -48.8% | |
| May 11, 2023 | Q1 2023 | -$0.17Est: -$0.19 | +10.5% | $254.0KEst: $1.1M | -76.9% |
We use cookies for analytics. See our Privacy and Cookie Policy.